Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin t release in patients with nonischemic heart failure

American Journal of Cardiology

Volumn 113, Issue 10, 2014, Pages 1697-1704

  Takashio, Seiji ^a   Yamamuro, Megumi ^a   Uemura, Tomoaki ^a   Utsunomiya, Daisuke ^a   Morita, Kosuke ^a   Izumiya, Yasuhiro ^a   Sugiyama, Seigo ^a   Kojima, Sunao ^a   Yamamoto, Eiichiro ^a   Tsujita, Kenichi ^a   Tanaka, Tomoko ^a   Tayama, Shinji ^a   Kaikita, Koichi ^a   Hokimoto, Seiji ^a   Yasuda, Osamu ^a   Yamashita, Yasuyuki ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; LOOP DIURETIC AGENT; TROPONIN T;

ADULT; AORTA ROOT; ARTICLE; CARDIOVASCULAR CATHETER; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; FEMALE; HEART FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

CARDIAC CATHETERIZATION; CARDIOMYOPATHIES; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TROPONIN T;

EID: 84899898930     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.02.029     Document Type: Article

References (30)

1. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, and G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
2. C. Kawahara, T. Tsutamoto, K. Nishiyama, M. Yamaji, H. Sakai, M. Fujii, T. Yamamoto, and M. Horie Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy Circ J 75 2011 656 661
3. T. Kubo, H. Kitaoka, S. Yamanaka, T. Hirota, Y. Baba, K. Hayashi, T. Iiyama, N. Kumagai, K. Tanioka, N. Yamasaki, Y. Matsumura, T. Furuno, T. Sugiura, and Y.L. Doi Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy J Am Coll Cardiol 62 2013 1252 1259
4. T.J. Wu, J.J. Ong, C. Hwang, J.J. Lee, M.C. Fishbein, L. Czer, A. Trento, C. Blanche, R.M. Kass, W.J. Mandel, H.S. Karagueuzian, and P.S. Chen Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry J Am Coll Cardiol 32 1998 187 196
5. D.L. Mann, and M.R. Bristow Mechanisms and models in heart failure: the biomechanical model and beyond Circulation 111 2005 2837 2849
6. E. Kehr, M. Sono, S.S. Chugh, and M. Jerosch-Herold Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro Int J Cardiovasc Imaging 24 2008 61 68
7. K.C. Wu, R.G. Weiss, D.R. Thiemann, K. Kitagawa, A. Schmidt, D. Dalal, S. Lai, D.A. Bluemke, G. Gerstenblith, E. Marbán, G.F. Tomaselli, and J.A. Lima Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Col Cardiol 51 2008 2414 2421
8. O. Bruder, A. Wagner, C.J. Jensen, S. Schneider, P. Ong, E.M. Kispert, K. Nassenstein, T. Schlosser, G.V. Sabin, U. Sechtem, and H. Mahrholdt Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
9. G. Todiere, G.D. Aquaro, P. Piaggi, F. Formisano, A. Barison, P.G. Masci, E. Strata, L. Bacigalupo, M. Marzilli, A. Pingitore, and M. Lombardi Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 60 2012 922 929
10. A. Gulati, A. Jabbour, T.F. Ismail, K. Guha, J. Khwaja, S. Raza, K. Morarji, T.D. Brown, N.A. Ismail, M.R. Dweck, E. Di Pietro, M. Roughton, R. Wage, Y. Daryani, R. O'Hanlon, M.N. Sheppard, F. Alpendurada, A.R. Lyon, S.A. Cook, M.R. Cowie, R.G. Assomull, D.J. Pennell, and S.K. Prasad Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 309 2013 896 908
11. W.J. Kop, J.S. Gottdiener, C.R. deFilippi, E. Barasch, S.L. Seliger, N.S. Jenny, and R.H. Christenson Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged ≥65 years with heart failure Circ Heart Fail 5 2012 406 413
12. S.A. Hunt ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 e82
13. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Strömberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, and Swedberg ESC guidelines for the diagnosis and treatment of acute and chronicheart failure 2008: the Task Force for the diagnosis and treatment of acute and chronicheart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
14. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A.S. Jaffe, and H.A.K. Katus Analytical validation of a high-sensitivity cardiac troponin T assay Clin Chem 56 2010 254 261
15. G.D. Aquaro, V. Positano, A. Pingitore, E. Strata, G. Di Bella, F. Formisano, P. Spirito, and M. Lombardi Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 12 2010 21
16. A.S. Flett, J. Hasleton, C. Cook, D. Hausenloy, G. Quarta, C. Ariti, V. Muthurangu, and J.C. Moon Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance JACC Cardiovasc Imaging 4 2011 150 156
17. S. Takashio, M. Yamamuro, Y. Izumiya, S. Sugiyama, S. Kojima, E. Yamamoto, K. Tsujita, T. Tanaka, S. Tayama, K. Kaikita, S. Hokimoto, and H. Ogawa Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure J Am Coll Cardiol 62 2013 623 640
18. S. Schalla, S.C. Bekkers, R. Dennert, R.J. van Suylen, J. Waltenberger, T. Leiner, J. Wildberger, H.J. Crijns, and S. Heymans Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy Eur J Heart Fail 12 2010 227 231
19. M.S. Gandhi, G. Kamalov, A.U. Shahbaz, S.K. Bhattacharya, R.A. Ahokas, Y. Sun, I.C. Gerling, and K.T. Weber Cellular and molecular pathways to myocardial necrosis and replacement fibrosis Heart Fail Rev 16 2011 23 34
20. K.T. Weber, and C.G. Brilla Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1991 1849 1865
21. M. Aragno, R. Mastrocola, G. Alloatti, I. Vercellinatto, P. Bardini, S. Geuna, M.G. Catalano, O. Danni, and G. Boccuzzi Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats Endocrinology 149 2008 380 388
22. E.E. Creemers, and Y.M. Pinto Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart Cardiovasc Res 89 2011 265 272
23. T. Tsutamoto, C. Kawahara, M. Yamaji, K. Nishiyama, M. Fujii, T. Yamamoto, and M.A. Horie Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure Eur J Heart Fail 11 2009 653 658
24. A.S. Jaffe, V.C. Vasile, M. Milone, A.K. Saenger, K.N. Olson, and F.S. Apple Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T J Am Coll Cardiol 58 2011 1819 1824
25. T. Omland, J.A. de Lemos, M.S. Sabatine, C.A. Christophi, M.M. Rice, K.A. Jablonski, S. Tjora, M.J. Domanski, B.J. Gersh, J.L. Rouleau, M.A. Pfeffer, and E. Braunwald A sensitivecardiactroponin T assay in stable coronary artery N Engl J Med 361 2009 2538 2547
26. S. Masson, I. Anand, C. Favero, S. Barlera, T. Vago, F. Bertocchi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J.N. Cohn, and R. Latini Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials Circulation 125 2012 280 288
27. F. Zannad, F. Alla, B. Dousset, A. Perez, B. Pitt
28. D.J. Lok, S.I. Lok, P.W. Bruggink-André de la Porte, E. Badings, E. Lipsic, J. van Wijngaarden, R.A. de Boer, D.J. van Veldhuisen, and P. van der Meer Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure Clin Res Cardiol 102 2013 103 110
29. B. López, A. González, and J. Díez Circulating biomarkers of collagen metabolism in cardiac diseases Circulation 121 2010 1645 1654
30. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368